Neimeth International Pharmaceuticals Plc (NGX: NEIMETH)

Market Cap	7.91B
Revenue (ttm)	3.79B
Net Income (ttm)	-1.98B
Shares Out	4.27B
EPS (ttm)	-0.46
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	552,755
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	1.510 - 2.450
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 29, 2024

About NEIMETH

Neimeth International Pharmaceuticals Plc manufactures and markets pharmaceutical and animal health care products in Nigeria and Ghana. The company operates through two segments, Pharmaceuticals and Animal Health. It also provides health care, ethical, and veterinary related products; and poultry and a range of anthelmintic products, as well as enhancing medicaments. The company was formally known as Pfizer Inc. and changed its name to Neimeth International Pharmaceuticals Plc. In 1997. Neimeth International Pharmaceuticals Plc was incorporated...

• Industry: Pharmaceutical Preparations
• Founded: 1957
• Employees: 202
• Stock Exchange: Nigerian Stock Exchange
• Ticker Symbol: NEIMETH

Financial Performance

In 2023, NEIMETH's revenue was 2.21 billion, a decrease of -24.31% compared to the previous year's 2.92 billion. Losses were -2.87 billion, 781.5% more than in 2022.